Remifemin Preventing the Climacteric Symptoms in Breast Cancer
Clinical trial NCT03339882 · COMPLETED
Trial details
- NCT number
- NCT03339882
- Sponsor
- Zhejiang Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-04
- Primary completion
- 2017-11-27
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.